Villaño Valencia, Débora
Loading...
Email Address
person.page.identifierURI
Birth Date
Job Title
Last Name
Villaño Valencia
First Name
Débora
person.page.departamento
Agronomía, Biotecnología y Alimentación
person.page.instituteName
IS-FOOD. Research Institute on Innovation & Sustainable Development in Food Chain
ORCID
person.page.observainves
person.page.upna
Name
- Publications
- item.page.relationships.isAdvisorOfPublication
- item.page.relationships.isAdvisorTFEOfPublication
- item.page.relationships.isAuthorMDOfPublication
3 results
Search Results
Now showing 1 - 3 of 3
Publication Open Access Effects of long-term consumption of broccoli sprouts on inflammatory markers in overweight subjects(Elsevier, 2018-03-13) López-Chillón, María Teresa; Carazo-Díaz, Carmen; Prieto-Merino, David; Zafrilla, Pilar; Moreno, Diego A.; Villaño Valencia, Débora; Agronomía, Biotecnología y Alimentación; Agronomia, Bioteknologia eta ElikaduraBackground & aims. Broccoli sprouts represent an interesting choice of healthy food product as they are rich in glucosinolates and their cognate bioactive metabolites, isothiocyanates able to counteract the negative effects of diverse pathologies. As obesity is linked to an inflammatory component, the aim of the study was to evaluate the anti-inflammatory action of broccoli sprouts in overweight adult subjects. Methods. An in vivo controlled study was performed in 40 healthy overweight subjects (ClinicalTrials.gov ID NCT 03390855). Treatment phase consisted on the consumption of broccoli sprouts (30 g/day) during 10 weeks and the follow-up phase of 10 weeks of normal diet without consumption of these broccoli sprouts. Anthropometric parameters as body fat mass, body weight, and BMI were determined. Inflammation status was assessed by measuring levels of TNF-α, IL-6, IL-1β and C-reactive protein. Results. IL-6 levels significantly decreased (mean values from 4.76 pg/mL to 2.11 pg/mL with 70 days of broccoli consumption, p < 0.001) and during control phase the inflammatory levels were maintained at low grade (mean values from 1.20 pg/mL to 2.66 pg/mL, p < 0.001). C-reactive protein significantly decreased as well. Conclusions. This study represents an advance in intervention studies as the broccoli sprouts were included in a daily dietary pattern in quantities that reflect a real consumption. Further studies are necessary to elucidate the role of this healthy rich and nutritious food product, but these promising results support the current evidence on the healthy properties of Brassica varieties.Publication Open Access Bioavailability of broccoli sprouts in different human overweight populations(Elsevier, 2019-06-10) Villaño Valencia, Débora; López-Chillón, María Teresa; Zafrilla, Pilar; Moreno, Diego A.; Agronomía, Biotecnología y Alimentación; Agronomia, Bioteknologia eta ElikaduraBroccoli sprouts rich in glucosinolates have shown interesting properties mitigating the inflammatory status linked to obesity. Studies performed in healthy lean subjects have shown that these compounds possess good bioavailability, however long-term studies in overweight populations are scarce. The aim of this study was to evaluate the bioavailability of broccoli sprouts in overweight adults: men, non-menopausal women and post-menopausal women. An in vivo controlled parallel study was performed in 69 healthy overweight subjects that consumed broccoli sprouts (30 g/day) during 5 weeks, with a follow-up phase of 5 weeks of normal diet without broccoli sprouts. Trial registered at ClinicalTrials.gov as NCT03390855. Metabolites from glutathione detoxification pathway increased in all groups after 5 weeks of broccoli consumption, especially in post-menopausal women (Sulphoraphane-N-Acetyl cysteine levels from 0.0656 nmol/mg creatinine to 1.8191 nmol/mg creatinine, p < 0.001) and similar behaviour was observed for Sulphoraphane and Sulphoraphane-Cysteine. Post-menopausal condition was associated with higher levels of metabolites.Publication Open Access Anthocyanin metabolites in human urine after the intake of new functional beverages(MDPI, 2020) Agulló, Vicente; Villaño Valencia, Débora; García-Viguera, Cristina; Domínguez-Perles, Raúl; Agronomía, Biotecnología y Alimentación; Agronomia, Bioteknologia eta Elikadura; Institute on Innovation and Sustainable Development in Food Chain - ISFOODSugar intake abuse is directly related with the increase of metabolic diseases such as type 2 diabetes, obesity, and insulin resistance. Along this line, the development of new beverages using alternative sweeteners could help with combatting the pathophysiological disorders associated to the consumption of sugar. To provide evidence on this issue, in the present work, the bioavailability of anthocyanins was evaluated after the acute ingestion of a new maqui-citrus-based functional beverage rich in polyphenols, and supplemented with a range of sweeteners including sucrose (natural high caloric), stevia (natural non-caloric), and sucralose (artificial non-caloric), as an approach that would allow reducing the intake of sugars while providing bioactive phenolic compounds (anthocyanins). This approach allowed the evaluation of the maximum absorption and the diversity of metabolites excreted through urine. The beverages created were ingested by volunteers (n = 20) and the resulting anthocyanin metabolites in their urine were analyzed by UHPLC-ESI-MS/MS. A total of 29 degradation metabolites were detected: Caffeic acid, catechol, 3,4-dihidroxifenilacetic acid, hippuric acid, trans-ferulic acid, 2,4,6-trihydroxybenzaldehyde, trans-isoferulic acid, and vanillic acid derivatives, where peak concentrations were attained at 3.5 h after beverage intake. Sucralose was the sweetener that provided a higher bioavailability for most compounds, followed by stevia. Sucrose did not provide a remarkably higher bioavailability of any compounds in comparison with sucralose or stevia. The results propose two sweetener alternatives (sucralose and stevia) to sucrose, an overused high calorie sweetener that promotes some metabolic diseases.